Literature DB >> 17045842

Angiopoietins: a link between angiogenesis and inflammation.

Ulrike Fiedler1, Hellmut G Augustin.   

Abstract

The angiopoietin (Ang)-Tie ligand-receptor system has a key regulatory role in regulating vascular integrity and quiescence. Besides its role in angiogenesis, it is an important regulator in numerous diseases including inflammation. Ang-1-mediated Tie2 activation is required to maintain the quiescent resting state of the endothelium. Agonistic Ang-1 functions are antagonized by Ang-2, which is believed to inhibit Ang-1-Tie2 signaling. Ang-2 destabilizes the quiescent endothelium and primes it to respond to exogenous stimuli, thereby facilitating the activities of inflammatory (tumor necrosis factor and interleukin-1) and angiogenic (vascular endothelial growth factor) cytokines. Intriguingly, Ang-2 is expressed weakly by the resting endothelium but becomes strongly upregulated following endothelial activation. Moreover, endothelial cells store Ang-2 in Weibel-Palade bodies from where it can be made available quickly following stimulation, suggesting a role of Ang-2 in controlling rapid vascular adaptive processes. This suggests that Ang-2 is the dynamic regulator of the Ang-Tie2 axis, thereby functioning as a built-in switch controlling the transition of the resting quiescent endothelium towards the activated responsive endothelium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045842     DOI: 10.1016/j.it.2006.10.004

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  220 in total

1.  Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells.

Authors:  Debanjan Chakroborty; Chandrani Sarkar; Hongmei Yu; Jiang Wang; Zhongfa Liu; Partha Sarathi Dasgupta; Sujit Basu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

Review 2.  "Go with the flow": how Krüppel-like factor 2 regulates the vasoprotective effects of shear stress.

Authors:  Lalitha Nayak; Zhiyong Lin; Mukesh K Jain
Journal:  Antioxid Redox Signal       Date:  2011-04-15       Impact factor: 8.401

Review 3.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

4.  Brain pericytes: emerging concepts and functional roles in brain homeostasis.

Authors:  Masahiro Kamouchi; Tetsuro Ago; Takanari Kitazono
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

5.  Angiopoietin-2-driven vascular remodeling in airway inflammation.

Authors:  Sebastien P Tabruyn; Katharine Colton; Tohru Morisada; Jonas Fuxe; Stanley J Wiegand; Gavin Thurston; Anthony J Coyle; Jane Connor; Donald M McDonald
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

Review 6.  Novel antiangiogenic agents in dermatology.

Authors:  Ricardo L Berrios; Jack L Arbiser
Journal:  Arch Biochem Biophys       Date:  2010-12-21       Impact factor: 4.013

Review 7.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

8.  Immature myeloid cells are critical for enhancing bone fracture healing through angiogenic cascade.

Authors:  Seth Levy; Joseph M Feduska; Anandi Sawant; Shawn R Gilbert; Jonathan A Hensel; Selvarangan Ponnazhagan
Journal:  Bone       Date:  2016-09-21       Impact factor: 4.398

9.  Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.

Authors:  Sirpa Loukovaara; Kaisa Lehti; Alexandra Robciuc; Timo Pessi; Juha M Holopainen; Katri Koli; Ilkka Immonen; Jorma Keski-Oja
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-12       Impact factor: 3.117

10.  Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.

Authors:  Tsin W Yeo; Daniel A Lampah; Retno Gitawati; Emiliana Tjitra; Enny Kenangalem; Kim Piera; Ric N Price; Stephen B Duffull; David S Celermajer; Nicholas M Anstey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.